Sustained elevation of calcium induces Ca(2+)/calmodulin-dependent protein kinase II clusters in hippocampal neurons

Neuroscience. 2001;106(1):69-78. doi: 10.1016/s0306-4522(01)00262-7.

Abstract

Treatment of cultured hippocampal neurons with the mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP) in the absence of glucose mimics ischemic energy depletion and induces formation of Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) clusters, spherical structures with diameters of 75-175 nm [Dosemeci et al., J. Neurosci. 20 (2000) 3076-3084]. The demonstration that CaMKII clustering occurs in the intact, adult rat brain upon interruption of blood flow indicates that clustering is not confined to cell cultures. Application of N-methyl-D-aspartate (250 microM, 15 min) to hippocampal cultures also induces cluster formation, suggesting a role for Ca(2+). Indeed, intracellular Ca(2+) monitored with Fluo3-AM by confocal microscopy reaches a sustained high level within 5 min of CCCP treatment. The appearance of immunolabeled CaMKII clusters, detected by electron microscopy, follows the onset of the sustained increase in intracellular Ca(2+). Moreover, CaMKII does not cluster when the rise in intracellular Ca(2+) is prevented by the omission of extracellular Ca(2+) during CCCP treatment, confirming that clustering is Ca(2+)-dependent. A lag period of 1-2 min between the onset of high intracellular Ca(2+) levels and the formation of CaMKII clusters suggests that a sustained increase in Ca(2+) level is necessary for the clustering. CaMKII clusters disappear within 2 h of returning the cultures to normal incubation conditions, at which time no significant cell death is detected. These results indicate that pathological conditions that promote sustained episodes of Ca(2+) overload result in a transitory clustering of CaMKII into spherical structures. CaMKII clustering may represent a cellular defense mechanism to sequester a portion of the CaMKII pool, thereby preventing excessive protein phosphorylation.

MeSH terms

  • Age Factors
  • Animals
  • Calcium / metabolism*
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases / drug effects
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone / pharmacology
  • Cell Culture Techniques
  • Cells, Cultured / enzymology
  • Cells, Cultured / pathology
  • Cells, Cultured / ultrastructure
  • Chelating Agents / pharmacology
  • Cytoplasm / enzymology
  • Cytoplasm / pathology
  • Cytoplasm / ultrastructure
  • Energy Metabolism / drug effects
  • Energy Metabolism / physiology*
  • Excitatory Amino Acid Agonists / pharmacology
  • Extracellular Space / drug effects
  • Extracellular Space / enzymology
  • Fetus
  • Hippocampus / enzymology*
  • Hippocampus / pathology
  • Hippocampus / physiopathology
  • Immunohistochemistry
  • Intracellular Fluid / drug effects
  • Intracellular Fluid / enzymology*
  • Microscopy, Electron
  • N-Methylaspartate / pharmacology
  • Neurons / enzymology*
  • Neurons / pathology
  • Neurons / ultrastructure
  • Neurotoxins / pharmacology
  • Protein Structure, Tertiary / drug effects
  • Protein Structure, Tertiary / physiology
  • Rats
  • Rats, Sprague-Dawley
  • Time Factors
  • Uncoupling Agents / pharmacology

Substances

  • Chelating Agents
  • Excitatory Amino Acid Agonists
  • Neurotoxins
  • Uncoupling Agents
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone
  • N-Methylaspartate
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Calcium